Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Island Pharmaceuticals Limited (ILA.AX)

Compare
0.1600
-0.0050
(-3.03%)
At close: April 17 at 3:23:06 PM GMT+10
Currency in AUD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
1,251.5750
1,251.5750
11.0650
--
--
Gross Profit
1,251.5750
1,251.5750
11.0650
--
--
Operating Expense
4,125.3560
4,125.3560
2,908.1310
2,809.0050
2,138.9430
Operating Income
-2,873.7810
-2,873.7810
-2,897.0660
-2,809.0050
-2,138.9430
Net Non Operating Interest Income Expense
-41.4870
-41.4870
-9
--
--
Other Income Expense
50.9500
50.9500
75.6170
202.1180
12.1880
Pretax Income
-2,864.3180
-2,864.3180
-2,830.4490
-2,606.8870
-2,126.7550
Net Income Common Stockholders
-2,864.3180
-2,864.3180
-2,830.4490
-2,606.8870
-2,126.7550
Basic EPS
-0.03
--
-0.03
-0.03
-0.11
Diluted EPS
-0.03
--
-0.03
-0.03
-0.11
Basic Average Shares
90,295.6060
--
87,519.8880
87,156.1870
20,067.2120
Diluted Average Shares
90,295.6060
--
87,519.8880
87,156.1870
20,067.2120
Net Income from Continuing & Discontinued Operation
-2,864.3180
-2,864.3180
-2,830.4490
-2,606.8870
-2,126.7550
Normalized Income
-2,864.3180
-2,864.3180
-2,830.4490
-2,606.8870
-2,126.7550
Interest Income
4.7140
4.7140
--
--
--
Interest Expense
46.2010
46.2010
9
--
--
Net Interest Income
-41.4870
-41.4870
-9
--
--
EBIT
-2,818.1170
-2,818.1170
-2,821.4490
-2,809.0050
-2,138.9430
EBITDA
-2,818.1170
-2,818.1170
-2,821.4490
-2,809.0050
-2,138.9430
Net Income from Continuing Operation Net Minority Interest
-2,864.3180
-2,864.3180
-2,830.4490
-2,606.8870
-2,126.7550
Normalized EBITDA
-2,818.1170
-2,818.1170
-2,821.4490
-2,809.0050
-2,138.9430
6/30/2021 - 4/13/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers